Hypoxia training suppresses harmful cardiac nitric oxide production during heart attack

Researchers at the University of North Texas Health Science Center, Fort Worth, Texas have demonstrated that, contrary to prevailing dogma, hypoxia can be remarkably beneficial to the heart.

These discoveries, to be reported in the June 2008 issue of Experimental Biology and Medicine, may lead to a new paradigm to protect hearts of patients at risk of coronary disease. Hypoxia is generally considered harmful to the heart, since a steady supply of oxygen is required to maintain cardiac function.

However, this research has demonstrated that a 20 day program of brief, repetitive, moderate reductions in the amount of oxygen in the arterial blood induce adaptations which increase the heart’s resistance to the more severe insult of a heart attack. In particular, intermittent hypoxic treatment of dogs remarkably reduced myocardial infarction and lethal arrhythmias following coronary artery occlusion and reperfusion.

The research team, led by Robert T. Mallet, Associate Professor of Integrative Physiology, H. Fred Downey, Regents Professor of Integrative Physiology, and doctoral student Myoung-Gwi Ryou explored mechanisms that may be responsible for this remarkable cardioprotection. Specifically, the investigators tested the hypothesis that intermittent hypoxia treatment suppressed harmful over-production of nitric oxide, the precursor of a host of toxic compounds, by heart tissue upon coronary artery reperfusion.

One day after completing 20 days of intermittent hypoxia treatment, dogs were anesthetized and a coronary artery was surgically obstructed for 60 minutes, and then the obstruction was removed and artery was reperfused. An explosive burst of cardiac nitric oxide production occurred during the first few minutes of reperfusion in untreated dogs, but this harmful burst was considerably dampened in hypoxia-treated dogs, without compromising recovery of coronary blood flow. Hypoxia treatment also suppressed cardiac activity of nitric oxide synthase (NOS), the enzyme that produces nitric oxide, as well as the heart’s content of the principal NOS isoform, endothelial NOS.

According to Dr. Mallet, “reduced NOS activity may contribute to the cardiac benefits of hypoxia treatment by decreasing formation of a free radical, superoxide, as well as nitric oxide. Both of these compounds are produced by NOS. When these two compounds are produced simultaneously, they combine to form peroxynitrite, an extremely aggressive chemical by-product that injures the heart by damaging the molecular components of cells. By decreasing NOS activity in the heart, hypoxia treatment could minimize formation of peroxynitrite and other harmful products of nitric oxide and superoxide.”

“Intermittent hypoxia treatment may be a powerful adjunctive therapy for patients at risk of heart disease” says Dr. Downey. “The brief periods of moderate hypoxia are easily tolerated by most people, require neither surgery nor expensive medications, and can be administered by the patient at home or work using available devices. Indeed, intermittent hypoxia has been used for several decades in Eastern Europe to treat heart and neurological diseases and high blood pressure.” Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine stated “This study by Robert Mallet and colleagues may suggest a simple treatment to minimize the impact of a heart attack and should stimulate further study of this phenomena”.

Source: Society for Experimental Biology and Medicine

Related stories:

Mice with a migraine show signs of brain damage
Migraines may be doing more than causing people skull-splitting pain. Scientists have found evidence that the headaches may also be acting like tiny transient strokes, leaving parts of the brain starved for oxygen and altering the brain in significant ways.
Researchers discover 'sticky' proteins fuse adult stem cells to cardiac muscle, repairing hearts
Cardiologists are increasingly using adult stem cells in clinical trials to repair hearts following heart attacks, but no one has understood how the therapy actually works. Now, in animal experiments, researchers at The University of Texas M. D. Anderson Cancer Center have deconstructed the process, describing how the stem cells fuse with heart muscle cells to create new cells that repopulate the ailing organ.
Viagra improves high altitude exercise performance up to 45 per cent for some
Sildenafil (Viagra) significantly improved the cardiovascular and exercise performance measures of trained cyclists at high altitude, mostly because the drug helped some participants improve a lot -- up to 45% -- while others showed little change. Sildenafil provided no benefit at sea level.
Olympic Games: Have we reached a plateau in terms of speed?
The world-record pace for the marathon continues to improve for both men and women. For men, the record pace for the marathon is now about as fast as the record pace for the 10,000-meter run just after World War II. Today, champion athletes are running more than four times farther at speeds of well under five minutes per mile.
Large dead zones predicted for Gulf, Chesapeake Bay
Record-setting "dead zones" in the Gulf of Mexico and Chesapeake Bay appear likely this summer, according to new forecasts from a University of Michigan researcher.
Solid tumor cells not killed by radiation and chemotherapy become stronger
Because of the way solid tumors adapt the body's machinery to bring themselves more oxygen, chemotherapy and radiation may actually make these tumors stronger.
Researchers identify genetic markers that predict efficacy of novel cancer drug
Researchers at the University of Southern California (USC) and USC/Norris Comprehensive Cancer Center have identified genetic markers in cancer cells that predicted the benefit of a novel cancer drug prior to chemotherapy.
A new gene trigger for pregnancy disorder identified
The COMT gene – known already for its role in schizophrenia – has been found to play a role in preeclampsia, according to a report in today’s advance on-line issue of Nature.

News discussion:

Medicine & Health news